Overexpression of IL-7Rα provides a competitive advantage during early T-cell development

被引:36
作者
Laouar, Y
Crispe, IN
Flavell, RA
机构
[1] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA
[2] Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY USA
[3] Howard Hughes Med Inst, New Haven, CT 06510 USA
关键词
D O I
10.1182/blood-2003-06-2126
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Critical checkpoints controlling early thymic T-cell development and homeostasis are set by the proper signaling function of the interleukin 7 receptor (IL-7R) and the pre-T-cell antigen receptor. Although alphabeta T-cell development is observed in IL-7- and IL-7Ralpha-deficient mice, the number of thymocytes is significantly reduced, implying a role for the IL-7R in controlling the size of the thymic T-cell compartment. Here, we report the overexpression of IL-7Ralpha that occurs in the early T-cell compartment from AKR/J mice, animals that are highly susceptible to the spontaneous development of thymoma. Increased IL-7Ralpha was revealed by surface staining, and increased IL-7Ralpha. mRNA was documented by using reverse transcriptase-polymerase chain reaction (RT-PCR). This resulted in increased survival of AKR/J early thymocytes, shown by the decreased frequency of TUNEL+ (terminal deoxynucleotidyl transferase mediated deoxyuridine triphosphate [dUTP]-fluorescein nick end labeling) cells. In an in vivo thymocyte repopulation model, AKR/J thymocytes had a selective advantage over healthy thymocytes. This advantage occurred at early stages of T-cell development. Our findings support the model that overexpression of growth factor receptors can contribute to proliferation and malignancy. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:1985 / 1994
页数:10
相关论文
共 59 条
[1]   The role of mel-18, a mammalian Polycomb group gene, during IL-7-dependent proliferation of lymphocyte precursors [J].
Akasaka, T ;
Tsuji, K ;
Kawahira, H ;
Kanno, M ;
Harigaya, K ;
Hu, LN ;
Ebihara, Y ;
Nakahata, T ;
Tetsu, O ;
Taniguchi, M ;
Koseki, H .
IMMUNITY, 1997, 7 (01) :135-146
[2]   Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice [J].
Akashi, K ;
Kondo, M ;
vonFreedenJeffry, U ;
Murray, R ;
Weissman, IL .
CELL, 1997, 89 (07) :1033-1041
[3]   Multiple γc-receptor expression in adult T-cell leukemia [J].
Baba, H ;
Yamada, Y ;
Mori, N ;
Hayashibara, T ;
Harasawa, H ;
Tsuruda, K ;
Sugahara, K ;
Soda, H ;
Takasaki, Y ;
Tawara, M ;
Hirakata, Y ;
Tomonaga, M ;
Kamihira, S .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2002, 68 (06) :362-369
[4]   Interleukin-7 receptor expression in cutaneous T-cell lymphomas [J].
Bagot, M ;
Charue, D ;
Boulland, ML ;
Gaulard, P ;
Revuz, J ;
Schmitt, C ;
Wechsler, J .
BRITISH JOURNAL OF DERMATOLOGY, 1996, 135 (04) :572-575
[5]   Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27kip1 [J].
Barata, JT ;
Cardoso, AA ;
Nadler, LM ;
Boussiotis, VA .
BLOOD, 2001, 98 (05) :1524-1531
[6]   THE EFFECT OF IN-VIVO IL-7 DEPRIVATION ON T-CELL MATURATION [J].
BHATIA, SK ;
TYGRETT, LT ;
GRABSTEIN, KH ;
WALDSCHMIDT, TJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (04) :1399-1409
[7]  
Bolotin E, 1996, BLOOD, V88, P1887
[8]   Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count [J].
Bolotin, E ;
Annett, G ;
Parkman, R ;
Weinberg, K .
BONE MARROW TRANSPLANTATION, 1999, 23 (08) :783-788
[9]   Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease [J].
Cavazzana-Calvo, M ;
Hacein-Bey, S ;
Basile, CD ;
Gross, F ;
Yvon, E ;
Nusbaum, P ;
Selz, F ;
Hue, C ;
Certain, S ;
Casanova, JL ;
Bousso, P ;
Le Deist, F ;
Fischer, A .
SCIENCE, 2000, 288 (5466) :669-672
[10]   Radiosensitivity of thymic interleukin-7 production and thymopoiesis after bone marrow transplantation [J].
Chung, B ;
Barbara-Burnham, L ;
Barsky, L ;
Weinberg, K .
BLOOD, 2001, 98 (05) :1601-1606